# Nasdaq

Type: Company (NDAQ)

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/nasdaq
Canonical HTML page: https://getlegalbrief.com/entity/nasdaq

## Timeline

- **2026-10-01**: Pilot Program — Expected launch of a pilot program for select S&P 500 stocks on the new DLT infrastructure.
- **2026-07-13**: Compliance Demands & Legal Pursuit Announced — Company announces it will submit compliance demands to clearinghouses and prime brokers ahead of mandatory legal action for FTDs and volume anomalies, and unveils a forensic audit strategy.
- **2026-07-06**: Retention of Christian Attar — DBGI retained the law firm Christian Attar to investigate potential naked short selling and market manipulation of its common shares.
- **2026-03-19**: SEC Approval — The SEC grants Nasdaq the authority to move public equity settlement to a blockchain ledger.
- **2026-03-18**: SEC Approval — The SEC officially grants Nasdaq the authority to trade and settle tokenized securities.
- **2026**: ICE Announcement — Intercontinental Exchange reveals development of a platform for on-chain settlement of securities.
- **2025-09**: Initial Filing — Nasdaq files a proposal with the SEC to amend rules for tokenized trading on its main market.
- **2024-05-28**: T+1 Implementation — U.S. markets transition to a one-day settlement cycle to reduce systemic risk.
- **2015-12-30**: Linq Launch — Nasdaq successfully completes its first private share trade using blockchain technology.

## Recent coverage (5 stories)

### SEBI Praised Over Fidelity's 15-Day IPO Flip Ban: US Legality Questioned
2026-07-31 08:06:19 · Sentiment: Very Bullish · Impact: 6/10 · Sources: 2

Indian experts argue Fidelity's 15-day lock on SpaceX IPO shares violates investor rights, while SEBI's regulatory framework would never permit such a restriction. A legal analysis of broker-imposed trading limits and investor protection.
Full story: https://getlegalbrief.com/story/sebi-vs-us-ipo-flip-ban-15-day-legal

### DBGI Targets Shorts on 2 Exchanges with 3-Part Audit, Retains Christian Attar
2026-07-14 22:35:53 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Digital Brands Group escalates its fight against alleged naked short selling by demanding compliance from clearinghouses and threatening litigation, backed by a forensic audit and the retention of boutique law firm Christian Attar. The move signals a rare issuer-led enforcement initiative targeting cross-border settlement anomalies and FTDs, with significant implications for securities regulation and civil liability theories.
Full story: https://getlegalbrief.com/story/dbgi-naked-short-legal-pursuit-christian-attar

### SEC Greenlights Nasdaq's Blockchain Integration for Public Equities
2026-03-19 09:02:11 · Sentiment: Neutral · Impact: 9/10 · Sources: 2

The SEC has officially approved Nasdaq's proposal to integrate blockchain technology into its core trading infrastructure, marking a historic shift toward real-time settlement. This move transitions the traditional T+1 settlement cycle toward an 'atomic' model, potentially saving billions in collateral requirements and reducing systemic risk.
Full story: https://getlegalbrief.com/story/nasdaq-sec-blockchain-stock-market-approval

### Nasdaq Receives SEC Approval for Tokenized Securities Trading
2026-03-19 02:05:48 · Sentiment: Bullish · Impact: 8/10 · Sources: 2

The U.S. Securities and Exchange Commission (SEC) has approved a landmark proposal by Nasdaq to allow certain stocks and exchange-traded products to be traded and settled in tokenized form. This decision marks a significant integration of blockchain technology into mainstream equity markets, initially targeting high-volume securities within the Russell 1000 Index and major benchmark ETFs.
Full story: https://getlegalbrief.com/story/nasdaq-sec-approval-tokenized-securities

### Corcept Therapeutics Faces Securities Fraud Suit Over Disclosure Failures
2026-02-24 12:29:58 · Sentiment: Neutral · Impact: 5/10 · Sources: 10

Corcept Therapeutics (NASDAQ: CORT) is the target of a class action lawsuit alleging securities fraud between October 2024 and December 2025. The Rosen Law Firm is leading the litigation, which centers on claims that the company misled investors regarding its business operations and regulatory compliance. This legal challenge marks a critical period of scrutiny for the pharmaceutical firm's corporate governance and public disclosure practices.
Full story: https://getlegalbrief.com/story/corcept-therapeutics-securities-fraud-lawsuit-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.